ArticleBMC urology2019
Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer.
Article in BMC urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 38 citations in OpenAlex.
- Retzius-sparing robotic radical prostatectomy: Insights and outcomes from the UAE experience.Journal of robotic surgery · 2026Article
- [Functional outcomes after robot-assisted laparoscopic prostatectomy (RALP) vs. open radical retropubic prostatectomy (RRP): critical analysis in the context of current evidence].Urologie (Heidelberg, Germany) · 2025Article
- Association between 3D membranous urethral parameters and urinary continence recovery after RARP.European journal of medical research · 2024Article
- Urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in relation to surgeon experience.Journal of robotic surgery · 2023Observational
- Transition from standard robotic prostatectomy to Retzius-sparing prostatectomy: feasibility and early outcomes.Journal of robotic surgery · 2023Article
- Comparison of single-port and multi-port Retzius-sparing robot-assisted laparoscopic prostatectomy.Journal of robotic surgery · 2023Article
- Retzius-Sparing Robotic-Assisted Prostatectomy: Technical Challenges for Surgeons and Key Prospective Refinements.Research and reports in urology · 2023Review
- Research progress on surgical factors related to early urinary control after laparoscopic radical prostatectomy.American journal of clinical and experimental urology · 2023Review
- Retzius-sparing technique independently predicts early recovery of urinary continence after robot-assisted radical prostatectomy.Journal of robotic surgery · 2022Article
- Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients.The Prostate · 2022Article
- Retzius-sparing Robot-assisted Radical Prostatectomy in High-risk Prostate Cancer Patients: Results from a Large Single-institution Series.European urology open science · 2022Article
- Different Nerve-Sparing Techniques during Radical Prostatectomy and Their Impact on Functional Outcomes.Cancers · 2022Review
- A retrospective study to evaluate the effect of preoperative hormonal therapy on continence recovery.Frontiers in oncology · 2022Article
- Efficacy and safety of single port robotic radical prostatectomy and multiport robotic radical prostatectomy: a systematic review and meta-analysis.Translational andrology and urology · 2021Article
- How to Prevent and Manage Post-Prostatectomy Incontinence: A Review.The world journal of men's health · 2021Review
- Complex space of Retzius lymphocele resulting in iliac compression and submassive pulmonary embolism after robotic Retzius sparing prostatectomy.Urology case reports · 2021Article
- Retzius-sparing robotic-assisted laparoscopic radical prostatectomy: racial considerations for 250 consecutive cases.Journal of robotic surgery · 2021Article
- The impact of transition from conventional robot-assisted radical prostatectomy to retzius sparing robot-assisted radical prostatectomy: A retrospective multivariate analysis.Indian journal of urology : IJU : journal of the Urological Society of IndiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRetzius-sparing robot-assisted laparoscopic radical prostatectomy (rsRARP) allows entire prostatectomy procedure via the pouch of Douglas. In low- and intermediate-risk prostate cancer (PCa) there is level 1 evidence that the Retzius-sparing approach impacts early continence recovery. Since specific data on aggressive and locally advanced cancer is lacking and avoiding rsRARP is presently suggested, we investigated urinary and sexual recovery, perioperative complications and early oncologic outcomes after rsRARP in this particular cohort.
methodsProspectively collected data of 50 consecutive men (median age 66 years) with high-risk PCa who underwent rsRARP in a single institution was analysed retrospectively. The follow-up for all patients was 12 months after surgery.
results3 vs. 12 months after surgery, 82% vs. 98% of men used no pad or one safety pad and 50% vs. 72% used no pad. 89% of patients did not observe a decline of continence if postoperative radiotherapy was carried out. Considering the 17 preoperatively potent patients who underwent bi- or unilateral nerve-sparing surgery, 41% reported their first sexual intercourse within 1 year after rsRARP. 84% of patients had ≥pT3a disease and 42% positive surgical margins. A lymphadenectomy was done in 94% of patients with a median lymph node removal of 15 and lymph node metastasis in 13%. 34% underwent adjuvant radiotherapy and 22% adjuvant androgen deprivation therapy (ADT). 1-year recurrence-free survival was 96%, including 25% of patients on adjuvant or salvage ADT.
conclusionsRsRARP in high-risk PCa is feasible and results in excellent continence rates, even after postoperative radiotherapy. The potency rates are promising but need further clarification in larger cohorts. Reliable oncologic outcomes require longterm follow-up and are awaited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.